Waystar Holding Corp

Análisis de la acción Waystar Holding Corp (WAY)

$26.870

+0.583 (+2.17%)Al cierre

Loading chart…
Máximo
27.070
Apertura
25.970
Precio medio ponderado por volumen
26.64
Volumen
3.73M
Capitalización
—
Mínimo
25.970
Importe
99.25M
EV/EBITDA, TTM
13.05

Waystar Holding Corp. provides healthcare organizations with mission-critical cloud software that simplifies healthcare payments. The Company’s enterprise-grade platform, Waystar, streamlines the complex processes. It leverages internally developed artificial intelligence (AI) as well as proprietary, advanced algorithms to automate payment-related workflow tasks and drive continuous improvement, which enhances claim and billing accuracy, enriches data integrity, and reduces labor costs for providers. Its software is used daily by providers of all types and sizes across the continuum of care, including physician practices, clinics, surgical centers, and laboratories, as well as large hospitals and health systems. The Company’s clients utilize its software to manage pre-encounter workflows, such as eligibility checks and prior authorization approvals, as well as mid- and post-encounter workflows, such as co-pay collection, claims submission and monitoring, and payer remittances.

Análisis de IA of Waystar Holding Corp (WAY)

Comprar

Waystar Holding Corp is a good buy right now due to its current price of $26.68, which is below several analyst price targets, including $28 from Citi and $44 from RBC. The company has shown strong revenue growth of 18% year-over-year in Q2 2026, and its forward P/E ratio of 12.80 indicates it is potentially undervalued compared to its growth prospects. However, a risk to consider is the insider selling activity, which has increased by 280.05% over the last month, indicating potential concerns from insiders about the company's future performance.

Métricas de valoración

El PER previsto actual de Waystar Holding Corp (WAY) es 12.80, frente a su media de 5 años de 28.66.

PER previsto

Infravalorado
Media 5A P/E
28.66
P/E actual
12.80
Sobrevalorada
40.92
Infravalorada
16.40

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
15.28
EV/EBITDA actual
13.05
Sobrevalorada
18.55
Infravalorada
12.01

Precio/ventas previsto

Valor razonable
Media 5A P/S
4.84
P/S actual
3.59
Sobrevalorada
6.24
Infravalorada
3.44

Ballenas con WAY en cartera

A

Advent International, L.P.

+ Con en carteraWAY

+21.04%

Rentabilidad a 3 meses

B

Burgundy Asset Management Ltd.

+ Con en carteraWAY

+5.12%

Rentabilidad a 3 meses

J

Jaunty Global Limited

+ Con en carteraWAY

+0.65%

Rentabilidad a 3 meses

G

GoldenTree Asset Management LP

+ Con en carteraWAY

-14.57%

Rentabilidad a 3 meses

Preguntas frecuentes sobre WAY, respondidas por Alphio AI

Waystar Holding Corp. provides healthcare organizations with mission-critical cloud software that simplifies healthcare payments. The Company’s enterprise-grade platform, Waystar, streamlines the complex processes. It leverages internally developed artificial intelligence (AI) as well as proprietary, advanced algorithms to automate payment-related workflow tasks and drive continuous improvement, which enhances claim and billing accuracy, enriches data integrity, and reduces labor costs for providers. Its software is used daily by providers of all types and sizes across the continuum of care, including physician practices, clinics, surgical centers, and laboratories, as well as large hospitals and health systems. The Company’s clients utilize its software to manage pre-encounter workflows, such as eligibility checks and prior authorization approvals, as well as mid- and post-encounter workflows, such as co-pay collection, claims submission and monitoring, and payer remittances. It operates in the Technology sector (COMPUTER INTEGRATED SYSTEMS DESIGN industry).

Waystar Holding Corp is a good buy right now due to its current price of $26.68, which is below several analyst price targets, including $28 from Citi and $44 from RBC. The company has shown strong revenue growth of 18% year-over-year in Q2 2026, and its forward P/E ratio of 12.80 indicates it is potentially undervalued compared to its growth prospects. However, a risk to consider is the insider selling activity, which has increased by 280.05% over the last month, indicating potential concerns from insiders about the company's future performance.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar